This category needs an editor. We encourage you to help if you are qualified.
Volunteer, or read more about what this involves.
Related categories

54 found
Order:
1 — 50 / 54
  1. PharmAD-Ventures: A Feminist Analysis of the Pharmacological Imaginary of Alzheimer's Disease.Cecilia Åsberg & Jennifer Lum - 2009 - Body and Society 15 (4):95-117.
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  2. Caregiving Men of Alzheimer’s Disease Sufferers in Nuevo Leo´N : Experiences and Meanings.J. Azoh Barry - 2014 - Vulnerable Groups and Inclusion 5.
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  3. Qualitative Assessment of Self-Identity in Advanced Dementia.Sadhvi Batra, Jacqueline Anne Sullivan, Beverly Williams & David Geldmacher - 2015 - Dementia: The International Journal of Social Research and Practice:1-19.
    This study aimed to understand the preserved elements of self-identity in persons with moderate to severe dementia attributable to Alzheimer’s disease. A semi-structured interview was developed to explore the narrative self among residents with dementia in a residential care facility and residents without dementia in an independent living setting. The interviews were transcribed verbatim from audio recordings and analyzed for common themes, while being sensitive to possible differences between the groups. The participants with dementia showed evidence of self-reference even though (...)
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  4. Descartes RV 5-8. 14. 25 Diagnosis of Alzheimer's Disease 132 Down Syndrome 67. 132 Early Detection of Brain Pathology in Alzheimer's Disease 131-143. [REVIEW]C. Bernard - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 80--151.
    Remove from this list  
     
    Export citation  
     
    My bibliography  
  5. Comment on “The Emerging Roles of Cystatins in Alzheimer's Disease” DOI 10.1002/Bies.200900012.Hans‐Gert Bernstein & Thomas M. Malone - 2009 - Bioessays 31 (9):1004-1005.
    Remove from this list   Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  6. Attentional Networks in Normal Aging and Alzheimer's Disease.Sandra E. Black - unknown
    By combining a flanker task and a cuing task into a single paradigm, the authors assessed the effects of orienting and alerting on conflict resolution and explored how normal aging and Alzheimer’s disease (AD) modulate these attentional functions. Orienting failed to enhance conflict resolution; alerting was most beneficial for trials without conflict, as if acting on response criterion rather than on information processing. Alerting cues were most effective in the older groups— healthy aging and AD. Conflict resolution was impaired only (...)
    Remove from this list  
    Translate
      Direct download  
     
    Export citation  
     
    My bibliography  
  7. The Enigma of the Brain and its Place as Cause, Character and Pretext in the Imaginary of Dementia.Alan Blum - 2012 - History of the Human Sciences 25 (4):108-124.
    An analysis of the collective engagement with the disease known as Alzheimer’s and the dementia reputed of it reveals recourse to a socially standardized formula that attributes causal agency to the brain in the absence of clinching knowledge. I propose that what Baudrillard calls the model of molecular idealism stipulates such a neurological view of determinism in order to provide caregivers with reassurance in the face of the perplexing character of dementia and the depressing reactions to mortality that it brings (...)
    Remove from this list   Direct download (7 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  8. Introduction: Neurophilosophy and Alzheimer's Disease.P. S. Churchland - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 1--4.
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  9. Alzheimer's Disease Untangled.Fiona Crawford & Alison Goate - 1992 - Bioessays 14 (11):727-734.
    Remove from this list   Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  10. Steps Towards a Mouse Model of Alzheimer's Disease.R. Anthony Crowther - 1995 - Bioessays 17 (7):593-595.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  11. Alzheimer's Disease and Impairment of the Self.M. N. Fargeau, N. Jaafari, S. Ragot, J. L. Houeto, C. Pluchon & R. Gil - 2010 - Consciousness and Cognition 19 (4):969-976.
    Impairment of the Self has been described in frontal–temporal dementia but little research has been carried out in patients with Alzheimer’s disease .ObjectiveThe aim of this study was to explore changes in the self in patients with AD.MethodForty-seven patients with mild to moderate AD were examined using a semi-structured scale designed to assess the self-concept along three dimensions, namely, the Material Self, the Social Self and the Spiritual Self.ResultsThe majority of patients presented impairment of at least one dimension of the (...)
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  12. Selective Attention in Early Dementia of Alzheimer Type.Diego Fernandez-Duque - manuscript
    This study explored possible deficits in selective attention brought about by Dementia of Alzheimer Type (DAT). In three experiments, we tested patients with early DAT, healthy elderly, and young adults under low memory demands to assess perceptual filtering, conflict resolution, and set switching abilities. We found no evidence of impaired perceptual filtering nor evidence of impaired conflict resolution in early DAT. In contrast, early DAT patients did exhibit a global cost in set switching consistent with an inability to maintain the (...)
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  13. In-Silico-Approaches and the Role of Ontologies in Aging Research.Georg Fuellen, Melanie Börries, Hauke Busch, Aubrey de Grey, Udo Hahn, Thomas Hiller, Andreas Hoeflich, Ludger Jansen, Georges E. Janssens, Christoph Kaleta, Anne C. Meinema, Sascha Schäuble, Paul N. Schofield, Barry Smith & Daniel Wuttke - 2013 - Rejuvenation Research 16 (6):540-546.
    The 2013 Rostock Symposium on Systems Biology and Bioinformatics in Aging Research was again dedicated to dissecting the aging process using in silico means. A particular focus was on ontologies, as these are a key technology to systematically integrate heterogeneous information about the aging process. Related topics were databases and data integration. Other talks tackled modeling issues and applications, the latter including talks focussed on marker development and cellular stress as well as on diseases, in particular on diseases of kidney (...)
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  14. Alzheimer's Disease, Aging, Chance, and Race.Atwood D. Gaines - 2006 - Philosophy, Psychiatry, and Psychology 13 (1):83-85.
  15. Building a Mystery: Alzheimer's Disease, Mild Cognitive Impairment, and Beyond.Atwood D. Gaines & Peter J. Whitehouse - 2006 - Philosophy, Psychiatry, and Psychology 13 (1):61-74.
    Remove from this list   Direct download (4 more)  
     
    Export citation  
     
    My bibliography  
  16. Spect Imaging In Alzheimer's Disease. B. Leanard Holman, Brigham And Women's Hospital.B. Leonard Holman, Keith A. Johnson & Thomas C. Hill - 1988 - Journal of Mind and Behavior 9 (3).
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  17. Ethics and Alzheimer's Disease: Widening the Lens.Martha B. Holstein - 1998 - Journal of Clinical Ethics 9 (1):13.
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography   1 citation  
  18. Neural Network Plasticity, BDNF and Behavioral Interventions in Alzheimer s Disease.P. Hubka - 2006 - Cognition 50 (56):57.
    Remove from this list  
     
    Export citation  
     
    My bibliography  
  19. No ECSIT-Stential Evidence for a Link with Alzheimer's Disease Yet.Tomer Illouz & Eitan Okun - 2015 - Bioessays 37 (1):5-5.
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  20. Relationships Between Psychosocial Stress, Cortisol, Apolipoprotein Є4, Beta-Amyloid, Hippocampal Volume, and Alzheimer's Disease in a Sample of South African Older Adults.Katharine Ann James - unknown
    Remove from this list  
     
    Export citation  
     
    My bibliography  
  21. Inflammation, Antichymotrypsin, and Lipid Metabolism: Autogenic Etiology of Alzheimer's Disease.S. Janciauskiene & H. T. Wright - 1998 - Bioessays 20 (12):1039-1046.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  22. The Neurological Disease Ontology.Mark Jensen, Alexander P. Cox, Naveed Chaudhry, Marcus Ng, Donat Sule Ray, William Duncan, Patrick, Bianca Weinstock-Guttman, Barry Smith, Alan Ruttenberg, Kinga Szigeti & Alexander D. Diehl - 2013 - Journal of Biomedical Semantics 4 (42).
    We are developing the Neurological Disease Ontology (ND) to provide a framework to enable representation of aspects of neurological diseases that are relevant to their treatment and study. ND is a representational tool that addresses the need for unambiguous annotation, storage, and retrieval of data associated with the treatment and study of neurological diseases. ND is being developed in compliance with the Open Biomedical Ontology Foundry principles and builds upon the paradigm established by the Ontology for General Medical Science (OGMS) (...)
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  23. Spect Imaging In Alzheimer's Disease. B. Leanard Holman, Brigham And Women's Hospital.Keith Johnson & Thomas Hill - 1988 - Journal of Mind and Behavior 9 (3).
    Remove from this list  
     
    Export citation  
     
    My bibliography  
  24. Alzheimer's Disease.Daniel I. Kaufer - 2002 - In Elaine Perry, Heather Ashton & Andrew W. Young (eds.), Neurochemistry of Consciousness: Neurotransmitters in Mind. John Benjamins. pp. 36--229.
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  25. Alzheimer Disease.Elizabeth A. Kensinger & Suzanne Corkin - 2002 - In Lynn Nadel (ed.), The Encyclopedia of Cognitive Science. Macmillan.
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  26. Alzheimer's Amyloid Beta Oligomers and Lipoprotein apoA?: Mistaken Identity is Possible.Natalia V. Koudinova - 2003 - Bioessays 25 (10):1024-1024.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  27. The Experimental Alzheimer's Disease Drug Posiphen [-Phenserine] Lowers Amyloid-Beta Peptide Levels in Cell Culture and Mice.D. K. Lahiri, D. Chen, B. Maloney, H. W. Holloway, Q. S. Yu, T. Utsuki, T. Giordano, K. Sambamurti & N. H. Greig - 2007 - J Pharmacol Exp Ther 320:386-96.
    Major characteristics of Alzheimer's disease are synaptic loss, cholinergic dysfunction, and abnormal protein depositions in the brain. The amyloid beta-peptide , a proteolytic fragment of amyloid beta precursor protein , aggregates to form neuritic plaques and has a causative role in AD. A present focus of AD research is to develop safe Abeta-lowering drugs. A selective acetylcholinesterase inhibitor, phenserine, in current human trials lowers both APP and Abeta. Phenserine is dose-limited in animals by its cholinergic actions; its cholinergically inactive enantiomer, (...)
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  28. Proline-Directed Phosphorylation and Isomerization in Mitotic Regulation and in Alzheimer's Disease.Kun Ping Lu, Yih-Cherng Liou & Inez Vincent - 2003 - Bioessays 25 (2):174-181.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  29. An ECSIT‐Centric View of Alzheimer's Disease (Comment on DOI 10.1002/Bies. 201100193).Mark P. Mattson - 2012 - Bioessays 34 (7):526-527.
    Remove from this list   Direct download (4 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  30. To Know or Not to Know - Ethical Issues Related to Early Diagnosis of Alzheimer's Disease.Niklas Mattsson, David Brax & Henrik Zetterberg - 2010 - International Journal of Alzheimer's Disease.
    In Alzheimer's disease (AD), pathological processes start in the brain long before clinical dementia. Biomarkers reflecting brain alterations may therefore indicate disease at an early stage, enabling early diagnosis. This raises several ethical questions and the potential benefits of early diagnosis must be weighted against possible disadvantages. Currently, there are few strong arguments favouring early diagnosis, due to the lack of disease modifying therapy. Also, available diagnostic methods risk erroneous classifications, with potentially grave consequences. However, a possible benefit of early (...)
    Remove from this list  
    Translate
      Direct download  
     
    Export citation  
     
    My bibliography  
  31. The Underestimated Potential of the Immune System in Prevention of Alzheimer's Disease Pathology.M. Hasan Mohajeri - 2007 - Bioessays 29 (9):927-932.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  32. The Cognitive Neuropsychology of Alzheimer's Disease.Robert D. Nebes - 2000 - In Martha J. Farah & Todd E. Feinberg (eds.), Patient-Based Approaches to Cognitive Neuroscience. MIT Press. pp. 369--375.
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  33. Dual Roles for Autophagy: Degradation and Secretion of Alzheimer's Disease Aβ Peptide.Per Nilsson & Takaomi C. Saido - 2014 - Bioessays 36 (6):570-578.
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  34. Alzheimer Neurodegeneration, Autophagy, and Abeta Secretion: The Ins and Outs.Ralph A. Nixon - 2014 - Bioessays 36 (6):547-547.
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  35. When Parsimony Backfires: Neglecting DNA Repair May Doom Neurons in Alzheimer's Disease.Thierry Nouspikel & Philip C. Hanawalt - 2003 - Bioessays 25 (2):168-173.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography   1 citation  
  36. Alzheimer's Disease Dietary Supplements in Websites.Nicole Palmour, Brandy L. Vanderbyl, Emma Zimmerman, Serge Gauthier & Eric Racine - 2013 - HEC Forum 25 (4):361-382.
  37. Alzheimer's Disease and Personhood.Erik Parens - 2013 - Hastings Center Report 43 (1):1 - p.
    Remove from this list   Direct download (5 more)  
     
    Export citation  
     
    My bibliography  
  38. Alzheimer Disease and the "Then" Self.Stephen G. Post - 1995 - Kennedy Institute of Ethics Journal 5 (4):307-321.
    Remove from this list   Direct download (5 more)  
     
    Export citation  
     
    My bibliography  
  39. The Moral Challenge of Alzheimer Disease.Stephen G. Post & Robert Young - 1997 - Bioethics 11 (2):177-178.
    Remove from this list  
     
    Export citation  
     
    My bibliography   8 citations  
  40. Cellular and Molecular Biology of Alzheimer's Disease.Donald L. Price, Edward H. Koo & Axel Unterbeck - 1989 - Bioessays 10 (2-3):69-74.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  41. Alzheimer's Disease, Tube Feeding, and Prudential Judgment.Vince A. Punzo - 2013 - The National Catholic Bioethics Quarterly 13 (3):469-482.
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  42. Alzheimer's Disease: Disruption of Mind-Brain Relations.S. I. Rapoport - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 86--107.
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  43. Alzheimer Vaccine: Amyloid-Β on Trial.Stephen R. Robinson, Glenda M. Bishop & Gerald Münch - 2003 - Bioessays 25 (3):283-288.
    Remove from this list   Direct download (2 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  44. Alzheimer Vaccine: An Update.Stephen R. Robinson, Glenda M. Bishop & Gerald Münch - 2003 - Bioessays 25 (10):1025-1025.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  45. Alzheimer Vaccine: Amyloid‐Β on Trial.Stephen R. Robinson, Glenda M. Bishop & Gerald Münch - 2003 - Bioessays 25 (3):283-288.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  46. Autonomy, Benevolence, and Alzheimer's Disease.Pam R. Sailors - 2001 - Cambridge Quarterly of Healthcare Ethics 10 (2):184-193.
    Medical ethics has traditionally been governed by two guiding, but sometimes conflicting, principlesthe Substituted Judgment Standard shows our concern for autonomy, whereas the Best Interest Standard shows our commitment to benevolence. Both standards are vulnerable to criticisms. Further, the principles can seem to offer conflicting prescriptions for action. The criticisms and conflict figure prominently in discussion of advance directive decisionmaking and Alzheimer's disease. After laying out each of the current standards and its problems, with Alzheimer's issues as my central concern, (...)
    Remove from this list   Direct download (5 more)  
     
    Export citation  
     
    My bibliography  
  47. The Moral Challenge of Alzheimer Disease.J. Savulescu - 1997 - Journal of Medical Ethics 23 (4):259-260.
    Remove from this list   Direct download (5 more)  
     
    Export citation  
     
    My bibliography  
  48. Consciousness: Evidence of Four Components in Alzheimer's Disease.J. L. Signoret - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 144--150.
    Remove from this list   Direct download  
     
    Export citation  
     
    My bibliography  
  49. Towards Alzheimer's Root Cause: ECSIT as an Integrating Hub Between Oxidative Stress, Inflammation and Mitochondrial Dysfunction.Montserrat Soler‐López, Nahuai Badiola, Andreas Zanzoni & Patrick Aloy - 2012 - Bioessays 34 (7):532-541.
    Remove from this list   Direct download (4 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  50. The Ethical Challenges of Alzheimer Disease and Our Ageing Population.Anna Stokes - 1998 - Chisholm Health Ethics Bulletin 4 (2):8.
    Remove from this list   Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
1 — 50 / 54